China Grand Pharmaceutical and Healthcare Holdings Ltd (512):企業の財務・戦略的SWOT分析

◆英語タイトル:China Grand Pharmaceutical and Healthcare Holdings Ltd (512) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15022
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:香港
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
China Grand Pharmaceutical and Healthcare Holdings Ltd (China Grand) is an investment holding company that develops, manufacture and distributes pharmaceutical preparations, medical devices and pharmaceutical intermediates, specialized raw materials, and healthcare products. The company provides product categories such as preparations, APIs, steroid hormones APIs, healthcare products and agricultural, fine chemicals, and others. It offers preparation products such as cardiovascular, ophthalmic gel and eye drops, antibacterial, antibiotics, and antipyretics and analgesic. China Grand provides raw materials such as amino acids and sterold hormones, among others. It distributes its products through a network of distributors in domestic and overseas markets. The company operates in Beijing, Hubei, Zhejiang, Hong Kong, and others. China Grand is headquartered in Hong Kong.

China Grand Pharmaceutical and Healthcare Holdings Ltd Key Recent Developments

Dec 31,2018: China Grand Pharmaceutical and Healthcare Holdings: Appointment of independent Non-Executive Director
Oct 29,2018: China Grand Pharm Granted the “GoldWing Award” for the Fastest Growing Company in Hong Kong Stock Connect

This comprehensive SWOT profile of China Grand Pharmaceutical and Healthcare Holdings Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of China Grand Pharmaceutical and Healthcare Holdings Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

China Grand Pharmaceutical and Healthcare Holdings Ltd – Key Information
China Grand Pharmaceutical and Healthcare Holdings Ltd – Overview
China Grand Pharmaceutical and Healthcare Holdings Ltd – Key Employees
China Grand Pharmaceutical and Healthcare Holdings Ltd – Key Employee Biographies
China Grand Pharmaceutical and Healthcare Holdings Ltd – Key Operational Heads
China Grand Pharmaceutical and Healthcare Holdings Ltd – Major Products and Services
China Grand Pharmaceutical and Healthcare Holdings Ltd – History
China Grand Pharmaceutical and Healthcare Holdings Ltd – Company Statement
China Grand Pharmaceutical and Healthcare Holdings Ltd – Locations And Subsidiaries
China Grand Pharmaceutical and Healthcare Holdings Ltd – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

China Grand Pharmaceutical and Healthcare Holdings Ltd – Business Description
China Grand Pharmaceutical and Healthcare Holdings Ltd – Corporate Strategy
China Grand Pharmaceutical and Healthcare Holdings Ltd – SWOT Analysis
SWOT Analysis – Overview
China Grand Pharmaceutical and Healthcare Holdings Ltd – Strengths
China Grand Pharmaceutical and Healthcare Holdings Ltd – Weaknesses
China Grand Pharmaceutical and Healthcare Holdings Ltd – Opportunities
China Grand Pharmaceutical and Healthcare Holdings Ltd – Threats
China Grand Pharmaceutical and Healthcare Holdings Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

China Grand Pharmaceutical and Healthcare Holdings Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

China Grand Pharmaceutical and Healthcare Holdings Ltd, Key Information
China Grand Pharmaceutical and Healthcare Holdings Ltd, Key Ratios
China Grand Pharmaceutical and Healthcare Holdings Ltd, Share Data
China Grand Pharmaceutical and Healthcare Holdings Ltd, Major Products and Services
China Grand Pharmaceutical and Healthcare Holdings Ltd, History
China Grand Pharmaceutical and Healthcare Holdings Ltd, Key Employees
China Grand Pharmaceutical and Healthcare Holdings Ltd, Key Employee Biographies
China Grand Pharmaceutical and Healthcare Holdings Ltd, Key Operational Heads
China Grand Pharmaceutical and Healthcare Holdings Ltd, Other Locations
China Grand Pharmaceutical and Healthcare Holdings Ltd, Subsidiaries
China Grand Pharmaceutical and Healthcare Holdings Ltd, Key Manufacturing facilities
China Grand Pharmaceutical and Healthcare Holdings Ltd, Key Competitors
China Grand Pharmaceutical and Healthcare Holdings Ltd, SWOT Analysis
China Grand Pharmaceutical and Healthcare Holdings Ltd, Ratios based on current share price
China Grand Pharmaceutical and Healthcare Holdings Ltd, Annual Ratios
China Grand Pharmaceutical and Healthcare Holdings Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

China Grand Pharmaceutical and Healthcare Holdings Ltd, Performance Chart
China Grand Pharmaceutical and Healthcare Holdings Ltd, Ratio Charts

★海外企業調査レポート[China Grand Pharmaceutical and Healthcare Holdings Ltd (512):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Confused.Com Limited:企業の戦略・SWOT・財務分析
    Confused.Com Limited - Strategy, SWOT and Corporate Finance Report Summary Confused.Com Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Atlantia SpA (ATL):企業の財務・戦略的SWOT分析
    Atlantia SpA (ATL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Flower Orthopedics Corp:医療機器:M&Aディール及び事業提携情報
    Summary Flower Orthopedics Corp (Flower Orthopedics) is a medical equipment provider that offers orthopedic devices. The company offers instrument kits which include K-wire kits, olive wire kits, guide wire kits, drill bit kits, lag screw kits, cannulated drill bits, trials and cannulated countersin …
  • Capita plc:企業の戦略・SWOT・財務情報
    Capita plc - Strategy, SWOT and Corporate Finance Report Summary Capita plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • MLM Biologics Inc:企業の製品パイプライン分析2018
    Summary MLM Biologics Inc (MLM Biologics) is a medical device company that provides optimum wound care management for patients and doctors. The company’s product includes bio-ConneKt Wound Matrix, a collagen-based wound dressing for chronic vascular ulcers, draining wounds, partial and full thicknes …
  • BioCryst Pharmaceuticals Inc (BCRX):企業の財務・戦略的SWOT分析
    BioCryst Pharmaceuticals Inc (BCRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Ems-Chemie Holding AG (EMSN):企業の財務・戦略的SWOT分析
    Summary Ems-Chemie Holding AG (Ems-Chemie) is a chemical company that manufactures and markets high performance polymers and specialty chemicals. The company's products include bonding products, polyamides, damping systems, sealants, coating products, thermoplastic material, technical fibers, and te …
  • Equinor ASA (EQNR):石油・ガス:M&Aディール及び事業提携情報
    Summary Equinor ASA (Equinor), formerly Statoil ASA, is an energy company. It focuses mainly on the exploration, development and production of crude oil and natural gas on the Norwegian Continental Shelf (NCS). The company also has operations in several of the important oil and gas provinces in the …
  • Enlight Renewable Energy Ltd (ENLT):企業の財務・戦略的SWOT分析
    Summary Enlight Renewable Energy Ltd (Enlight Renewable) is a renewable energy company that invests, develops, finances, constructs, operates and manages electricity production projects from renewable energy sources. The company develops photovoltaic technology by which solar energy is converted to …
  • Specialised Therapeutics Australia Pty Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Specialised Therapeutics Australia Pty Ltd (STA) is a biopharmaceutical company that develops and commercializes medicines in various therapeutic areas. The company’s products include abraxane, gliolan, oncotype dx, iclusig, oncotype dx prostate and aloxi. Its pipeline products comprise anam …
  • Interstate Hotels & Resorts Inc:戦略・SWOT・企業財務分析
    Interstate Hotels & Resorts Inc - Strategy, SWOT and Corporate Finance Report Summary Interstate Hotels & Resorts Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Yakult Honsha Co., Ltd.:企業の戦略・SWOT・財務分析
    Yakult Honsha Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Yakult Honsha Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Samyang Comtech Co., Ltd.:企業の戦略・SWOT・財務情報
    Samyang Comtech Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Samyang Comtech Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Synthonics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Synthonics Inc (Synthonics) is a pharmaceutical company that discovers, develops and licenses metal coordinated pharmaceuticals. The company uses unique metal coordination chemistry for modifying specific properties of patent-expiring pharmaceuticals. It develops MCP-311, a drug candidate th …
  • The Ambassador Hotel Co. Ltd.:企業の戦略・SWOT・財務情報
    The Ambassador Hotel Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Ambassador Hotel Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Teachers Insurance and Annuity Association of America (TIAA):企業の戦略・SWOT・財務情報
    Teachers Insurance and Annuity Association of America (TIAA) - Strategy, SWOT and Corporate Finance Report Summary Teachers Insurance and Annuity Association of America (TIAA) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers …
  • Yungjin Pharm Co Ltd (003520):製薬・医療:M&Aディール及び事業提携情報
    Summary Yungjin Pharm Co Ltd (Yungjin), a subsidiary of KT&G Corp is a pharmaceutical company that develops, manufactures and distributes active pharmaceutical ingredients, formulations and tonic drinks. The company provides API products such as cephalosporins and other general products. It also off …
  • Central Garden & Pet Company:企業の戦略・SWOT・財務情報
    Central Garden & Pet Company - Strategy, SWOT and Corporate Finance Report Summary Central Garden & Pet Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Tecpetrol SA:企業の戦略的SWOT分析
    Tecpetrol SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Themis Bioscience GmbH (THISR):製薬・医療:M&Aディール及び事業提携情報
    Summary Themis Bioscience GmbH (Themis Bioscience) is a biotechnology company that develops prophylactic vaccines for emerging tropical infections. The company develops emerging and specialist indications and vaccines from preclinical to late-stage clinical development phases. It develops novel vacc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆